Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
F1000Res ; 13: 8, 2024.
Article in English | MEDLINE | ID: mdl-38779317

ABSTRACT

Biomedical research projects are becoming increasingly complex and require technological solutions that support all phases of the data lifecycle and application of the FAIR principles. At the Berlin Institute of Health (BIH), we have developed and established a flexible and cost-effective approach to building customized cloud platforms for supporting research projects. The approach is based on a microservice architecture and on the management of a portfolio of supported services. On this basis, we created and maintained cloud platforms for several international research projects. In this article, we present our approach and argue that building customized cloud platforms can offer multiple advantages over using multi-project platforms. Our approach is transferable to other research environments and can be easily adapted by other projects and other service providers.


Subject(s)
Biomedical Research , Cloud Computing , Data Management , Humans , Data Management/methods
2.
Sci Rep ; 10(1): 1481, 2020 01 30.
Article in English | MEDLINE | ID: mdl-32001771

ABSTRACT

Cells need to preserve genome integrity despite varying cellular and physical states. p53, the guardian of the genome, plays a crucial role in the cellular response to DNA damage by triggering cell cycle arrest, apoptosis or senescence. Mutations in p53 or alterations in its regulatory network are major driving forces in tumorigenesis. As multiple studies indicate beneficial effects for hyperthermic treatments during radiation- or chemotherapy of human cancers, we aimed to understand how p53 dynamics after genotoxic stress are modulated by changes in temperature across a physiological relevant range. To this end, we employed a combination of time-resolved live-cell microscopy and computational analysis techniques to characterise the p53 response in thousands of individual cells. Our results demonstrate that p53 dynamics upon ionizing radiation are temperature dependent. In the range of 33 °C to 39 °C, pulsatile p53 dynamics are modulated in their frequency. Above 40 °C, which corresponds to mild hyperthermia in a clinical setting, we observed a reversible phase transition towards sustained hyperaccumulation of p53 disrupting its canonical response to DNA double strand breaks. Moreover, we provide evidence that mild hyperthermia alone is sufficient to induce a p53 response in the absence of genotoxic stress. These insights highlight how the p53-mediated DNA damage response is affected by alterations in the physical state of a cell and how this can be exploited by appropriate timing of combination therapies to increase the efficiency of cancer treatments.


Subject(s)
Genes, p53 , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , A549 Cells , Cell Proliferation , Combined Modality Therapy , DNA Breaks, Double-Stranded , DNA Damage , Humans , Hyperthermia, Induced , Lung Neoplasms/genetics , Lung Neoplasms/metabolism , Lung Neoplasms/therapy , Microscopy, Fluorescence , Mutation , Temperature , Time-Lapse Imaging
3.
Cell Rep ; 27(1): 48-58.e7, 2019 04 02.
Article in English | MEDLINE | ID: mdl-30943414

ABSTRACT

To enable reliable cell fate decisions, mammalian cells need to adjust their responses to dynamically changing internal states by rewiring the corresponding signaling networks. Here, we combine time-lapse microscopy of endogenous fluorescent reporters with computational analysis to understand at the single-cell level how the p53-mediated DNA damage response is adjusted during cell cycle progression. Shape-based clustering revealed that the dynamics of the CDK inhibitor p21 diverges from the dynamics of its transcription factor p53 during S phase. Using mathematical modeling, we predict and experimentally validate that S phase-specific degradation of p21 by PCNA-CRL4cdt2 is sufficient to explain these heterogeneous responses. This highlights how signaling pathways and cell regulatory networks intertwine to adjust the cellular response to the individual needs of a given cell.


Subject(s)
Cell Cycle/physiology , Cyclin-Dependent Kinase Inhibitor p21/metabolism , DNA Damage/physiology , Proliferating Cell Nuclear Antigen/physiology , Proteolysis , A549 Cells , Cell Cycle Checkpoints/physiology , Cells, Cultured , DNA Repair/physiology , Female , HEK293 Cells , Humans , MCF-7 Cells , Proliferating Cell Nuclear Antigen/genetics , Signal Transduction/genetics , Tumor Suppressor Protein p53/metabolism , Tumor Suppressor Protein p53/physiology
4.
Mol Syst Biol ; 14(1): e7733, 2018 01 25.
Article in English | MEDLINE | ID: mdl-29371237

ABSTRACT

The cytokine TGFß provides important information during embryonic development, adult tissue homeostasis, and regeneration. Alterations in the cellular response to TGFß are involved in severe human diseases. To understand how cells encode the extracellular input and transmit its information to elicit appropriate responses, we acquired quantitative time-resolved measurements of pathway activation at the single-cell level. We established dynamic time warping to quantitatively compare signaling dynamics of thousands of individual cells and described heterogeneous single-cell responses by mathematical modeling. Our combined experimental and theoretical study revealed that the response to a given dose of TGFß is determined cell specifically by the levels of defined signaling proteins. This heterogeneity in signaling protein expression leads to decomposition of cells into classes with qualitatively distinct signaling dynamics and phenotypic outcome. Negative feedback regulators promote heterogeneous signaling, as a SMAD7 knock-out specifically affected the signal duration in a subpopulation of cells. Taken together, we propose a quantitative framework that allows predicting and testing sources of cellular signaling heterogeneity.


Subject(s)
Single-Cell Analysis/methods , Smad2 Protein/metabolism , Smad4 Protein/metabolism , Systems Biology/methods , Transforming Growth Factor beta/pharmacology , Cell Line , Cell Nucleus/metabolism , Humans , Models, Theoretical , Organ Specificity , Signal Transduction
5.
BMC Genomics ; 16: 136, 2015 02 27.
Article in English | MEDLINE | ID: mdl-27391904

ABSTRACT

BACKGROUND: The analysis of differential splicing (DS) is crucial for understanding physiological processes in cells and organs. In particular, aberrant transcripts are known to be involved in various diseases including cancer. A widely used technique for studying DS are exon arrays. Over the last decade a variety of algorithms for the detection of DS events from exon arrays has been developed. However, no comprehensive, comparative evaluation including sensitivity to the most important data features has been conducted so far. To this end, we created multiple data sets based on simulated data to assess strengths and weaknesses of seven published methods as well as a newly developed method, KLAS. Additionally, we evaluated all methods on two cancer data sets that comprised RT-PCR validated results. RESULTS: Our studies indicated ARH as the most robust methods when integrating the results over all scenarios and data sets. Nevertheless, special cases or requirements favor other methods. While FIRMA was highly sensitive according to experimental data, SplicingCompass, MIDAS and ANOSVA showed high specificity throughout the scenarios. On experimental data ARH, FIRMA, MIDAS, and KLAS performed best. CONCLUSIONS: Each method shows different characteristics regarding sensitivity, specificity, interference to certain data settings and robustness over multiple data sets. While some methods can be considered as generally good choices over all data sets and scenarios, other methods show heterogeneous prediction quality on the different data sets. The adequate method has to be chosen carefully and with a defined study aim in mind.


Subject(s)
Algorithms , Alternative Splicing , Exons , RNA Splicing , RNA, Neoplasm/genetics , Humans , Sensitivity and Specificity
6.
Bioinformatics ; 24(7): 995-1001, 2008 Apr 01.
Article in English | MEDLINE | ID: mdl-18285370

ABSTRACT

MOTIVATION: Molecular diagnostics aims at classifying diseases into clinically relevant sub-entities based on molecular characteristics. Typically, the entities are split into subgroups, which might contain several variants yielding a hierarchical model of the disease. Recent years have introduced a plethora of new molecular screening technologies to molecular diagnostics. As a result molecular profiles of patients became complex and the classification task more difficult. RESULTS: We present a novel tool for detecting hierarchical structure in binary datasets. We aim for identifying molecular characteristics, which are stochastically implying other characteristics. The final hierarchical structure is encoded in a directed transitive graph where nodes represent molecular characteristics and a directed edge from a node A to a node B denotes that almost all cases with characteristic B also display characteristic A. Naturally, these graphs need to be transitive. In the core of our modeling approach lies the problem of calculating good transitive approximations of given directed but not necessarily transitive graphs. By good transitive approximation we understand transitive graphs, which differ from the reference graph in only a small number of edges. It is known that the problem of finding optimal transitive approximation is NP-complete. Here we develop an efficient heuristic for generating good transitive approximations. We evaluate the computational efficiency of the algorithm in simulations, and demonstrate its use in the context of a large genome-wide study on mature aggressive lymphomas. AVAILABILITY: The software used in our analysis is freely available from http://compdiag.uni-regensburg.de/software/transApproxs.shtml.


Subject(s)
Artificial Intelligence , Biomarkers, Tumor/analysis , Diagnosis, Computer-Assisted/methods , Lymphoma/diagnosis , Lymphoma/metabolism , Molecular Probe Techniques , Neoplasm Proteins/analysis , Pattern Recognition, Automated/methods , Algorithms , Humans , Reproducibility of Results , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...